glp-1 atrial fibrillation Impact of Receptor Agonist Therapy on Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis HRS 2026: GLP-1 Receptor Agonists

You might feel resentful that your weight loss journey was interrupted

You should always seek medical advice from a healthcare professional for any questions or concerns about your medical condition or treatment

They were never truly generics, and pharmacies cant label them as brand-name medications. Why this matters Compounded GLP-1s werent held to the same quality or safety standards as the brand-name versions

In the ATTAIN-1 Phase 3 trial, the most frequently reported adverse events with orforglipron 36 mg versus placebo were nausea (33.7% vs 10.4%), constipation (25.4% vs 9.3%), diarrhea (23.1% vs 9.6%), and vomiting (24.0% vs 4.0%)